Development of a preventive influenza D virus vaccine
AssigneeNUtech Ventures
InventorsQingsheng Li, Yanmin Wan, Feng Li
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a DNA vaccine or immunogenic composition expressing consensus hemagglutinin-esterase-fusion (HEF) protein (FluD-Vax) and a protein-based vaccine utilizing the HEF consensus protein. Methods of making and using the compositions are also provided herein.
Claims20
An immunogenic composition comprising a vector having an insert comprising a hemagglutinin esterase-fusion protein from the D/OK and D/660 strains of influenza D virus (IDV).
An immunogenic composition comprising a recombinant hemagglutinin esterase-fusion (HEF) protein from the D/OK and D/660 strains of IDV.
An immunogenic composition comprising a vector having an insert comprising a hemagglutinin esterase-fusion protein from influenza D virus (IDV), wherein said insert has a nucleotide sequence having at least 85% sequence homology with SEQ ID NO. 2.
An immunogenic composition comprising a recombinant hemagglutinin esterase-fusion (FIEF) protein from influenza D virus (IDV) wherein said protein is expressed by a nucleotide sequence having at least 85% sequence homology with SEQ ID NO. 2.
Dependencies are inferred from the claim text.